title: Natural autoantibodies to Fcγ receptors in intravenous immunoglobulins.
abstract: A considerable progress has been achieved in the comprehension of the cellular and molecular mechanisms that account for the therapeutic benefit of intravenous immunoglobulin (IVIg) in several autoimmune and inflammatory conditions. However, the precise mechanisms responsible for such a wide range of biological activities have not been proven unambiguously. A wide range of specificities have been identified within IVIg including idiotypes of immunoglobulins, T cell receptor, HLA molecules, several cell surface molecules of immunological importance such as CD4, CD5, Fas, BAFF, cytokines and cytokine receptors, chemokine receptors, CD40 among others. Here we identify and characterize the natural autoantibodies of IgG isotype directed against the human Fc receptors. We show that the F(ab')2 of IVIg recognize the FcγRIII (CD16) and FcγRII (CD32). Interestingly, the immunopurified anti-FcγIII and anti-FcγII antibodies isolated from IVIg bind soluble and membrane-bound FcR and inhibit rosette formation. Altogether, these results along with previous reports provide pointers on the existence of functionally relevant natural autoantibodies towards a wide range of self-motifs that may participate in regulation of the immune response. Their presence in the therapeutic immunoglobulin preparations may explain at least in part, the beneficial effect of IVIg in autoimmune diseases.
authors.affiliation: EA 4666 UFR de Médecine, CAP-Santé (FED 4231), Université de Picardie Jules Verne UPJV, Amiens, France.
authors.forename: Hicham
authors.initials: H
authors.lastname: Bouhlal
authors.forename: Denis
authors.initials: D
authors.lastname: Martinvalet
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Teillaud
authors.forename: Catherine
authors.initials: C
authors.lastname: Fridman
authors.forename: Michel D
authors.initials: MD
authors.lastname: Kazatchkine
authors.forename: Jagadeesh
authors.initials: J
authors.lastname: Bayry
authors.forename: Sébastien
authors.initials: S
authors.lastname: Lacroix-Desmazes
authors.forename: Srini V
authors.initials: SV
authors.lastname: Kaveri
mesh_terms: D001323:Autoantibodies / Q000276:immunology / Q000378:metabolism*; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D002846:Chromatography, Affinity; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D007113:Immunity, Innate; D007074:Immunoglobulin G / Q000276:immunology / Q000378:metabolism*; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000378:metabolism*; D007167:Immunotherapy / Q000379:methods*; D019169:Jurkat Cells; D017452:Receptors, IgG / Q000276:immunology
chemical_list: D001323:Autoantibodies; D016207:Cytokines; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D017452:Receptors, IgG